Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANDREW D PHAM

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1538588868
CMS profile
1395143
Location
WHITTIER, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$5,297.75

126 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,292.25 119
Consulting Fee $1,440.00 1
Long term medical supply or device loan $498.50 5
Education $67.00 1

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 126 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANDREW D PHAM

NPI 1538588868 · CMS profile ID 1395143

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

WHITTIER, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 126 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1538588868?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANDREW D PHAM, NPI 1538588868, CMS profile ID 1395143. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 126 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1538588868?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ANDREW D PHAM, NPI 1538588868, CMS profile ID 1395143. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 126 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1538588868?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ANDREW D PHAM, NPI 1538588868, CMS profile ID 1395143, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 126 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1538588868?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

126 matching records · $5,297.75 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 126 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 126.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
JAZZ PHARMACEUTICALS INC. $32.9608/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234319424 CMS
Novartis Pharmaceuticals Corporation $99.7008/21/2025 Long term medical supply or device loan No dispute reported Delay: No
Change: NEW
06/30/2026 1200736930 CMS
GENZYME CORPORATION $37.2008/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233612855 CMS
Stemline Therapeutics Inc. $34.5208/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244090059 CMS
Ipsen Biopharmaceuticals, Inc $34.1308/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208843363 CMS
Janssen Biotech, Inc. $19.8808/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174882840 CMS
SpringWorks Therapeutics, Inc. $24.5808/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232167636 CMS
Bayer Healthcare Pharmaceuticals Inc. $22.6308/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225702733 CMS
Kite Pharma, Inc. $24.6508/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212082753 CMS
Pharmacosmos Therapeutics Inc. $18.6608/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250729975 CMS
Gilead Sciences, Inc. $32.8408/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234424808 CMS
Daiichi Sankyo Inc. $29.2108/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197014131 CMS
CSL Behring $25.3007/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232384489 CMS
Alexion Pharmaceuticals, Inc. $22.2607/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202986458 CMS
PFIZER INC. $21.9407/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231673454 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.5807/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223853737 CMS
Merck Sharp & Dohme LLC $26.7107/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238238962 CMS
Novartis Pharmaceuticals Corporation $31.1107/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200736928 CMS
PUMA BIOTECHNOLOGY, INC. $26.7007/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251750856 CMS
Merck Sharp & Dohme LLC $23.7807/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238233385 CMS
GlaxoSmithKline, LLC. $67.0007/03/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1190716265 CMS
Genentech USA, Inc. $24.7507/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211493308 CMS
Janssen Biotech, Inc. $17.0507/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174882162 CMS
ARRAY BIOPHARMA INC $1,440.0006/27/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1231291139 CMS
Incyte Corporation $26.0306/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226095457 CMS
BeOne Medicines USA, Inc. $21.9706/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202900502 CMS
ADC THERAPEUTICS AMERICA, INC. $22.9606/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246127637 CMS
PFIZER INC. $15.0906/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228920935 CMS
Bayer Healthcare Pharmaceuticals Inc. $16.9406/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225702722 CMS
Coherus Oncology, Inc. $21.4406/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235239437 CMS
Daiichi Sankyo Inc. $27.4406/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197079207 CMS
E.R. Squibb & Sons, L.L.C. $17.7606/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184685815 CMS
Blueprint Medicines Corporation $25.5306/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235819574 CMS
ABBVIE INC. $24.1606/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1203604676 CMS
Merck Sharp & Dohme LLC $32.3806/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238284087 CMS
PFIZER INC. $22.2006/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231298407 CMS
Incyte Corporation $19.4005/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226164682 CMS
Merck Sharp & Dohme LLC $21.6805/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238058377 CMS
Janssen Biotech, Inc. $28.4405/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174881589 CMS
Novartis Pharmaceuticals Corporation $29.1605/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200736896 CMS
AstraZeneca Pharmaceuticals LP $127.3405/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207002750 CMS
PFIZER INC. $18.1005/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231705519 CMS
Eisai Inc. $22.8105/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244460014 CMS
Deciphera Pharmaceuticals Inc. $26.8205/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235960749 CMS
AstraZeneca Pharmaceuticals LP $21.2705/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206309058 CMS
Celgene Corporation $23.3005/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184685935 CMS
Merck Sharp & Dohme LLC $33.4905/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238327089 CMS
Novartis Pharmaceuticals Corporation $23.6905/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200736910 CMS
Boston Scientific Corporation $15.3105/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181271026 CMS
Lilly USA, LLC $34.2004/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186502243 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,091.96 98
PY2020 $1,266.48 50
PY2021 $11,772.40 120
PY2022 $8,907.97 73
PY2023 $10,189.94 18
PY2024 $4,732.82 84
PY2025 $5,297.75 126

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $12,413.00 11
PY2024 Principal investigator $110,358.43 14
PY2023 Principal investigator $23,377.59 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Exelixis Inc. $189.00 12/05/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385930
Principal investigator 1 Exelixis Inc. $1,310.00 11/03/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385928
Principal investigator 1 Exelixis Inc. $1,310.00 10/30/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385918
Principal investigator 1 Exelixis Inc. $189.00 09/05/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385908
Principal investigator 1 Exelixis Inc. $1,310.00 07/21/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385900
Principal investigator 1 Exelixis Inc. $189.00 07/01/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385902
Principal investigator 1 Exelixis Inc. $4,918.00 06/11/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385890
Principal investigator 1 Exelixis Inc. $1,310.00 04/28/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385888
Principal investigator 1 Exelixis Inc. $189.00 03/21/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385864
Principal investigator 1 Exelixis Inc. $1,310.00 03/03/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385852
Principal investigator 1 Exelixis Inc. $189.00 01/24/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY US INC
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer No dispute reported 06/30/2026 1222385856